Eli Lilly's Anti-Obesity Pill Maintains Weight Loss After Wegovy, Zepbound
The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, Thursday, Nov. 14, 2024.…
Pharmaceuticals
How donors, access and polls led Trump to reclassify marijuana
President Donald Trump's decision Thursday to sign an executive order easing federal restrictions on marijuana (and clearing the way for…
UnitedHealth Group Releases Independent Audit Results
A UnitedHealthcare sign is displayed on its office building in Minnetonka, Minnesota, U.S., on Dec. 11, 2025. Tim Evans |…
Trump reclassifies cannabis to Schedule III, easing restrictions on marijuana
US President Donald Trump sits in the Oval Office to sign executive orders, at the White House in Washington, DC,…
Medline Debuts on Nasdaq After Largest IPO of 2025
Shares of the American medical supply giant Medline jumped in its debut on the Nasdaq on Wednesday after the largest…
Eli Lilly's weight-loss drug retatrutide clears first late-stage study
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
Eli Lilly cuts cash prices on vials of weight-loss drug Zepbound
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
Novo Nordisk reduces Wegovy and Ozempic spot prices
Boxes of Ozempic and Wegovy manufactured by Novo Nordisk in a London pharmacy on March 8, 2024. Hollie Adams |…
Pfizer files second lawsuit against Novo Nordisk and Metsera
A Pfizer logo is displayed at a research center in the La Jolla neighborhood of San Diego, California, U.S., on…
Eli Lilly and Walmart to Offer Discounted Retail Option for Zepbound
The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, Thursday, Nov. 14, 2024.…